Dean Foods Company (NYSE:DF)
Dean Foods Company (NYSE:DF) represented a move of -0.5 percent or $-0.06 per share and closed its previous day trading session at $5.97. 5.49 Million Shares were traded in the last trading session with an Average Volume of 1.74 Million Shares. The stock currently has a Market Capitalization of 584.94 Million.
Dean Foods is a leading food and beverage company in the United States. The Company is one of the nation’s largest processors and direct-to-store distributors of fluid milk marketed under more than 50 local and regional dairy brands and private labels. They distribute ice cream, cultured products, juices, teas, bottled water and other products. Pure and simple, they ensure Mother Nature’s most perfect food finds a place in every home. It sell its products under approximately 50 national, regional, and local proprietary or licensed brands, and private labels, including DairyPure, TruMoo, Alta Dena, Berkeley Farms, Country Fresh, Dean?s, Friendly’s, Garelick Farms, LAND O LAKES, Lehigh Valley Dairy Farms, Mayfield, McArthur, Meadow Gold, Oak Farms, PET, T.G. Lee, Tuscan, and others. The company sells its products to retailers, distributors, foodservice outlets, educational institutions, and governmental entities through its sales forces.
The stock traded between $ 5.62 and $12.09 over 1-Year time period showing its price to sales ratio of 0.07. Dean Foods Company (NYSE:DF) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-20.06 and 200-Day Simple Moving Average of $-33.08. Its Price to Free Cash Flow is 13.26 and Price to Book of 0.9.
Analyst’s recommended the stock as 3.3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Dean Foods Company (NYSE:DF) reported its Actual EPS of $-0.28/share. The analysts offering Earnings Estimates for the company were believing that Dean Foods Company could bring EPS of $-0.06/share. The difference between Actual EPS and Estimated EPS was -0.22 Percent. Thus showing an Earnings Surprise of -366.7 Percent.
Astrazeneca PLC (NYSE:AZN)
In the last trading session, Astrazeneca PLC (NYSE:AZN) added its value by 3.67% closing at the price of $40.65. The stock currently has market capitalization of 103.13 Billion, with average volume of 4.19 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Astrazeneca PLC (NYSE:AZN) is showing beta of 0.53. This particular value of beta suggests that Astrazeneca PLC (NYSE:AZN) has historically moved 53% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Astrazeneca PLC (NYSE:AZN) is at $1.07.
The stock currently has RSI of 63.87. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Astrazeneca PLC (NYSE:AZN) topped its 52-week high price of $41.28 on 11/08/18 and 52-Week Low Price of $31.99 on 12/06/17. The Stock currently has P/E (price to earnings ttm) of 38.1 and Weekly volatility of 2.04% and monthly volatility of 2.02% respectively.